PDB-5qgg: 構造ビューア
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT7 in complex with FMOPL000693a
手法: X-RAY DIFFRACTION / 解像度: 1.91 Å

PDB-5qgh: 構造ビューア
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT7 in complex with FMOPL000420a
手法: X-RAY DIFFRACTION / 解像度: 1.82 Å

PDB-5qgi: 構造ビューア
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT7 in complex with FMOPL000710a
手法: X-RAY DIFFRACTION / 解像度: 1.95 Å

PDB-5qgj: 構造ビューア
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT7 in complex with FMOPL000706a
手法: X-RAY DIFFRACTION / 解像度: 1.95 Å

PDB-5qgk: 構造ビューア
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT7 in complex with FMOPL000679a
手法: X-RAY DIFFRACTION / 解像度: 1.81 Å

PDB-5qgl: 構造ビューア
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT7 in complex with FMOPL000275a
手法: X-RAY DIFFRACTION / 解像度: 2.27 Å

PDB-5qgm: 構造ビューア
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT7 in complex with OX-160
手法: X-RAY DIFFRACTION / 解像度: 1.96 Å

PDB-5qgn: 構造ビューア
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT7 in complex with OX-210
手法: X-RAY DIFFRACTION / 解像度: 1.95 Å

PDB-5qgo: 構造ビューア
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT7 in complex with OX-220
手法: X-RAY DIFFRACTION / 解像度: 1.82 Å

PDB-5qgp: 構造ビューア
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT7 in complex with OX-221
手法: X-RAY DIFFRACTION / 解像度: 2.09 Å

PDB-5qgq: 構造ビューア
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT7 in complex with OX-65
手法: X-RAY DIFFRACTION / 解像度: 1.95 Å

PDB-5qgr: 構造ビューア
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT7 in complex with FMOPL000022a
手法: X-RAY DIFFRACTION / 解像度: 1.96 Å

PDB-5qgs: 構造ビューア
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT7 in complex with FMOPL000476a
手法: X-RAY DIFFRACTION / 解像度: 1.55 Å

PDB-5qgt: 構造ビューア
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT7 in complex with FMOPL000609a
手法: X-RAY DIFFRACTION / 解像度: 1.97 Å

PDB-5qgu: 構造ビューア
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT7 in complex with FMOPL000747a
手法: X-RAY DIFFRACTION / 解像度: 1.71 Å

PDB-5qgv: 構造ビューア
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT7 in complex with UNUYB062989
手法: X-RAY DIFFRACTION / 解像度: 1.59 Å

PDB-5qgw: 構造ビューア
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT7 in complex with NUOOA000154
手法: X-RAY DIFFRACTION / 解像度: 1.94 Å

PDB-5qgx: 構造ビューア
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT7 in complex with NUOOA000155
手法: X-RAY DIFFRACTION / 解像度: 1.61 Å

PDB-5qgy: 構造ビューア
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT7 in complex with NUOOA000158
手法: X-RAY DIFFRACTION / 解像度: 1.72 Å

PDB-5qgz: 構造ビューア
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT7 in complex with NUOOA000161
手法: X-RAY DIFFRACTION / 解像度: 1.65 Å

PDB-5qh0: 構造ビューア
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT7 in complex with NUOOA000180
手法: X-RAY DIFFRACTION / 解像度: 1.57 Å

PDB-5qh1: 構造ビューア
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT7 in complex with NUOOA000181
手法: X-RAY DIFFRACTION / 解像度: 1.65 Å

PDB-5qh2: 構造ビューア
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT7 in complex with NUOOA000188
手法: X-RAY DIFFRACTION / 解像度: 1.74 Å

PDB-5qh3: 構造ビューア
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT7 in complex with NUOOA000191
手法: X-RAY DIFFRACTION / 解像度: 1.65 Å

PDB-5qh4: 構造ビューア
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT7 in complex with NUOOA000220a
手法: X-RAY DIFFRACTION / 解像度: 1.67 Å

PDB-5qh5: 構造ビューア
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT7 in complex with NUOOA000224a
手法: X-RAY DIFFRACTION / 解像度: 1.85 Å

PDB-5qh6: 構造ビューア
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT7 in complex with NUOOA000259a
手法: X-RAY DIFFRACTION / 解像度: 2 Å

PDB-5qh7: 構造ビューア
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT7 in complex with NUOOA000194a
手法: X-RAY DIFFRACTION / 解像度: 1.74 Å

PDB-5qh8: 構造ビューア
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT7 in complex with PCM-0102558
手法: X-RAY DIFFRACTION / 解像度: 1.75 Å

PDB-5qh9: 構造ビューア
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT7 in complex with PCM-0102716
手法: X-RAY DIFFRACTION / 解像度: 1.72 Å

PDB-5qhb: 構造ビューア
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT7 in complex with RK4-332
手法: X-RAY DIFFRACTION / 解像度: 1.57 Å

PDB-5qhc: 構造ビューア
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT7 in complex with RK4-337
手法: X-RAY DIFFRACTION / 解像度: 2.21 Å

PDB-5qhe: 構造ビューア
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT7 in complex with RK4-350
手法: X-RAY DIFFRACTION / 解像度: 1.74 Å

PDB-5qhf: 構造ビューア
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT7 in complex with NUOOA000301a
手法: X-RAY DIFFRACTION / 解像度: 1.67 Å

PDB-5qhg: 構造ビューア
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT7 in complex with NU000442a
手法: X-RAY DIFFRACTION / 解像度: 1.92 Å

PDB-5qhh: 構造ビューア
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT7 in complex with NU000443a
手法: X-RAY DIFFRACTION / 解像度: 1.52 Å

PDB-5qhi: 構造ビューア
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of human FAM83B in complex with FMOPL000271a
手法: X-RAY DIFFRACTION / 解像度: 1.73 Å

PDB-5qhj: 構造ビューア
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of human FAM83B in complex with FMOPL000709a
手法: X-RAY DIFFRACTION / 解像度: 1.68 Å

PDB-5qhk: 構造ビューア
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of human FAM83B in complex with FMOPL000010a
手法: X-RAY DIFFRACTION / 解像度: 1.61 Å

PDB-5qhl: 構造ビューア
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of human FAM83B in complex with FMOPL000551a
手法: X-RAY DIFFRACTION / 解像度: 1.68 Å

PDB-5qhm: 構造ビューア
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of human FAM83B in complex with OX-145
手法: X-RAY DIFFRACTION / 解像度: 1.79 Å

PDB-5qhn: 構造ビューア
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of human FAM83B in complex with FMOPL000622a
手法: X-RAY DIFFRACTION / 解像度: 1.73 Å

PDB-5qho: 構造ビューア
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of human FAM83B in complex with FMOPL000010a
手法: X-RAY DIFFRACTION / 解像度: 1.66 Å

PDB-5qhp: 構造ビューア
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of human FAM83B in complex with FMOPL000554a
手法: X-RAY DIFFRACTION / 解像度: 2.06 Å

PDB-5qhq: 構造ビューア
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of human FAM83B in complex with FMOPL000574a
手法: X-RAY DIFFRACTION / 解像度: 1.96 Å

PDB-5qhr: 構造ビューア
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of human FAM83B in complex with FMOPL000635a
手法: X-RAY DIFFRACTION / 解像度: 1.68 Å

PDB-5qhs: 構造ビューア
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of human FAM83B in complex with FF000014a
手法: X-RAY DIFFRACTION / 解像度: 1.95 Å

PDB-5qhu: 構造ビューア
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of human PARP14 Macrodomain 3 in complex with FMSOA000341b
手法: X-RAY DIFFRACTION / 解像度: 1.05 Å

PDB-5qhw: 構造ビューア
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of human PARP14 Macrodomain 3 in complex with FMOPL000347a
手法: X-RAY DIFFRACTION / 解像度: 1.12 Å

PDB-5qhx: 構造ビューア
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of human PARP14 Macrodomain 3 in complex with FMOPL000278a
手法: X-RAY DIFFRACTION / 解像度: 1.11 Å

PDB-5qhy: 構造ビューア
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of human PARP14 Macrodomain 3 in complex with FMOPL000462a
手法: X-RAY DIFFRACTION / 解像度: 1.17 Å

PDB-5qhz: 構造ビューア
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of human PARP14 Macrodomain 3 in complex with FMOPL000385a
手法: X-RAY DIFFRACTION / 解像度: 1.15 Å

PDB-5qi0: 構造ビューア
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of human PARP14 Macrodomain 3 in complex with FMOPL000352a
手法: X-RAY DIFFRACTION / 解像度: 1.05 Å

PDB-5qi1: 構造ビューア
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of human PARP14 Macrodomain 3 in complex with FMOPL000474a
手法: X-RAY DIFFRACTION / 解像度: 1.05 Å

PDB-5qi2: 構造ビューア
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of human PARP14 Macrodomain 3 in complex with FMOPL000110a
手法: X-RAY DIFFRACTION / 解像度: 1.08 Å

PDB-5qi3: 構造ビューア
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of human PARP14 Macrodomain 3 in complex with FMOPL000475a
手法: X-RAY DIFFRACTION / 解像度: 1.05 Å

PDB-5qi5: 構造ビューア
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of human PARP14 Macrodomain 3 in complex with FMOPL000633a
手法: X-RAY DIFFRACTION / 解像度: 1.05 Å

PDB-5qi7: 構造ビューア
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of human PARP14 Macrodomain 3 in complex with FMOPL000506a
手法: X-RAY DIFFRACTION / 解像度: 1.05 Å

PDB-5qia: 構造ビューア
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of human PARP14 Macrodomain 3 in complex with FMOPL000242a
手法: X-RAY DIFFRACTION / 解像度: 1.14 Å

PDB-5qib: 構造ビューア
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of HAO1 in complex with FMOPL000388a
手法: X-RAY DIFFRACTION / 解像度: 1.48 Å

PDB-5qic: 構造ビューア
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of HAO1 in complex with Z30620520
手法: X-RAY DIFFRACTION / 解像度: 1.34 Å

PDB-5qid: 構造ビューア
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of HAO1 in complex with Z1787627869
手法: X-RAY DIFFRACTION / 解像度: 1.45 Å

PDB-5qie: 構造ビューア
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of HAO1 in complex with Z2856434894
手法: X-RAY DIFFRACTION / 解像度: 1.34 Å

PDB-5qif: 構造ビューア
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of HAO1 in complex with Z31792168
手法: X-RAY DIFFRACTION / 解像度: 1.2 Å

PDB-5qig: 構造ビューア
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of HAO1 in complex with Z1407672867
手法: X-RAY DIFFRACTION / 解像度: 1.42 Å

PDB-5qih: 構造ビューア
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of HAO1 in complex with Z2697514548
手法: X-RAY DIFFRACTION / 解像度: 1.33 Å

PDB-5qj4: 構造ビューア
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT5 in complex with Z1827602749
手法: X-RAY DIFFRACTION / 解像度: 1.89 Å

PDB-5qj6: 構造ビューア
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT5 in complex with Z1614545742
手法: X-RAY DIFFRACTION / 解像度: 1.65 Å

PDB-5qj7: 構造ビューア
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT5 in complex with Z32327641
手法: X-RAY DIFFRACTION / 解像度: 1.56 Å

PDB-5qj8: 構造ビューア
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT5 in complex with Z2856434829
手法: X-RAY DIFFRACTION / 解像度: 1.76 Å

PDB-5qj9: 構造ビューア
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT5 in complex with Z768399682
手法: X-RAY DIFFRACTION / 解像度: 1.85 Å

PDB-5qja: 構造ビューア
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT5 in complex with Z1497321453
手法: X-RAY DIFFRACTION / 解像度: 1.64 Å

PDB-5qjb: 構造ビューア
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT5 in complex with Z1787627869
手法: X-RAY DIFFRACTION / 解像度: 1.66 Å

PDB-5qjc: 構造ビューア
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT5 in complex with Z755044716
手法: X-RAY DIFFRACTION / 解像度: 1.47 Å

PDB-5qjd: 構造ビューア
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT5 in complex with Z240297434
手法: X-RAY DIFFRACTION / 解像度: 1.61 Å

PDB-5qje: 構造ビューア
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT5 in complex with Z275181224
手法: X-RAY DIFFRACTION / 解像度: 1.75 Å

PDB-5qjf: 構造ビューア
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT5 in complex with Z52425517
手法: X-RAY DIFFRACTION / 解像度: 1.63 Å

PDB-5qjg: 構造ビューア
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT5 in complex with Z44567722
手法: X-RAY DIFFRACTION / 解像度: 1.57 Å

PDB-5qjh: 構造ビューア
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT5 in complex with Z375990520
手法: X-RAY DIFFRACTION / 解像度: 2.03 Å

PDB-5qji: 構造ビューア
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT5 in complex with Z1899842917
手法: X-RAY DIFFRACTION / 解像度: 1.69 Å

PDB-5qjj: 構造ビューア
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT5 in complex with Z24758179
手法: X-RAY DIFFRACTION / 解像度: 1.71 Å

PDB-5qjk: 構造ビューア
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT5 in complex with Z373221060
手法: X-RAY DIFFRACTION / 解像度: 1.65 Å

PDB-5qjl: 構造ビューア
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT5 in complex with Z56983806
手法: X-RAY DIFFRACTION / 解像度: 1.66 Å

PDB-5qjm: 構造ビューア
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT5 in complex with Z328695024
手法: X-RAY DIFFRACTION / 解像度: 1.75 Å

PDB-5qjn: 構造ビューア
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT5 in complex with Z1439422127
手法: X-RAY DIFFRACTION / 解像度: 1.77 Å

PDB-5qjo: 構造ビューア
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT5 in complex with Z57292369
手法: X-RAY DIFFRACTION / 解像度: 1.98 Å

PDB-5qjp: 構造ビューア
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT5 in complex with Z1578665941
手法: X-RAY DIFFRACTION / 解像度: 1.5 Å

PDB-5qjq: 構造ビューア
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT5 in complex with Z56791867
手法: X-RAY DIFFRACTION / 解像度: 1.55 Å

PDB-5qjr: 構造ビューア
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT5 in complex with Z220816104
手法: X-RAY DIFFRACTION / 解像度: 1.62 Å

PDB-5qjs: 構造ビューア
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT5 in complex with Z979145504
手法: X-RAY DIFFRACTION / 解像度: 1.58 Å

PDB-5qjt: 構造ビューア
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT5 in complex with Z969560582
手法: X-RAY DIFFRACTION / 解像度: 1.62 Å

PDB-5qju: 構造ビューア
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT5 in complex with Z906021418
手法: X-RAY DIFFRACTION / 解像度: 1.77 Å

PDB-5qjv: 構造ビューア
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT5 in complex with Z281802060
手法: X-RAY DIFFRACTION / 解像度: 1.61 Å

PDB-5qjw: 構造ビューア
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT5 in complex with Z198194396
手法: X-RAY DIFFRACTION / 解像度: 1.57 Å

PDB-5qjx: 構造ビューア
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT5 in complex with Z2856434778
手法: X-RAY DIFFRACTION / 解像度: 1.73 Å

PDB-5qjy: 構造ビューア
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT5 in complex with Z94597856
手法: X-RAY DIFFRACTION / 解像度: 1.77 Å

PDB-5qjz: 構造ビューア
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT5 in complex with Z1696822287
手法: X-RAY DIFFRACTION / 解像度: 1.52 Å

PDB-5qk0: 構造ビューア
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT5 in complex with Z1270312110
手法: X-RAY DIFFRACTION / 解像度: 1.44 Å

PDB-5qk1: 構造ビューア
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT5 in complex with Z2027049478
手法: X-RAY DIFFRACTION / 解像度: 1.49 Å

PDB-5qk2: 構造ビューア
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT5 in complex with Z54628578
手法: X-RAY DIFFRACTION / 解像度: 1.65 Å

PDB-5qk3: 構造ビューア
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT5 in complex with Z239136710
手法: X-RAY DIFFRACTION / 解像度: 1.71 Å

PDB-5qk4: 構造ビューア
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT5 in complex with Z44590919
手法: X-RAY DIFFRACTION / 解像度: 1.62 Å

PDB-5qk5: 構造ビューア
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT5 in complex with Z1267773786
手法: X-RAY DIFFRACTION / 解像度: 1.63 Å

PDB-5qk6: 構造ビューア
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT5 in complex with Z1343633025
手法: X-RAY DIFFRACTION / 解像度: 1.51 Å

PDB-5qk7: 構造ビューア
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT5 in complex with Z1918536193
手法: X-RAY DIFFRACTION / 解像度: 1.66 Å

PDB-5qk8: 構造ビューア
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT5 in complex with Z1271660837
手法: X-RAY DIFFRACTION / 解像度: 1.71 Å

PDB-5qk9: 構造ビューア
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT5 in complex with Z102895082
手法: X-RAY DIFFRACTION / 解像度: 1.56 Å

PDB-5qka: 構造ビューア
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT5 in complex with Z2377835233
手法: X-RAY DIFFRACTION / 解像度: 1.55 Å

ChemComp-ACT: 構造ビューア
ACETATE ION / 酢酸イオン

ChemComp-DMS: 構造ビューア
DIMETHYL SULFOXIDE / 2-チアプロパン2-オキシド / DMSO, 沈殿剤*YM

ChemComp-H2G: 構造ビューア
(2S)-1-{[(5-methylthiophen-2-yl)methyl]amino}propan-2-ol

ChemComp-HOH: 構造ビューア
WATER

ChemComp-H2D: 構造ビューア
(2R)-N-(1,2-oxazol-3-yl)-2-phenylbutanamide

ChemComp-B0V: 構造ビューア
2-methoxy-~{N}-(2,4,6-trimethylphenyl)ethanamide

ChemComp-H1A: 構造ビューア
2-ethyl-N-(2-hydroxyphenyl)butanamide

ChemComp-H0S: 構造ビューア
N-(4-methylphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine

ChemComp-H5A: 構造ビューア
3,4,5-trimethoxybenzoic acid / 3,4,5-トリメトキシ安息香酸

ChemComp-H4Y: 構造ビューア
1-(4'-methoxy[1,1'-biphenyl]-2-yl)pyrrolidin-2-one

ChemComp-H4D: 構造ビューア
3-borono-5-{[(thiophen-2-yl)acetyl]amino}benzoic acid

ChemComp-H4A: 構造ビューア
(3aR,4R,6R,7R,8aR)-6-phenyloctahydro-1H-3a,7-epiminocyclohepta[c]pyrrol-4-ol

ChemComp-H3Y: 構造ビューア
(3aR,4S,6R,7R,8aR)-6-phenyloctahydro-1H-3a,7-epiminocyclohepta[c]pyrrol-4-ol

ChemComp-H3J: 構造ビューア
3-methyl-2-[(pyridin-3-yl)oxy]cyclopenta-2,4-dien-1-one

ChemComp-H0J: 構造ビューア
5-(pyridin-2-yl)thiophene-2-carbothioamide

ChemComp-H0D: 構造ビューア
N-(4-chlorophenyl)-N'-[(2R)-1-hydroxybutan-2-yl]urea

ChemComp-H04: 構造ビューア
1-(2-ethoxyphenyl)piperazine / 1-(2-エトキシフェニル)ピペラジン

ChemComp-H3G: 構造ビューア
(4-tert-butylpiperidin-1-yl)(phenyl)methanone

ChemComp-H3A: 構造ビューア
N-(3-chlorophenyl)-2-(3-methoxyphenyl)acetamide

ChemComp-H2Y: 構造ビューア
2-(4-methoxyphenyl)-N-(pyridin-3-yl)acetamide

ChemComp-H2J: 構造ビューア
N-(3-chlorophenyl)-2-(4-methoxyphenyl)acetamide

ChemComp-H1Y: 構造ビューア
N-(3-chlorophenyl)-2-phenylacetamide / N-(3-クロロフェニル)ベンゼンアセトアミド

ChemComp-H1J: 構造ビューア
N-(3-chlorophenyl)-2-(4-fluorophenyl)acetamide

ChemComp-H0P: 構造ビューア
2-(3-hydroxyphenyl)-N-(pyridin-3-yl)acetamide

ChemComp-H5G: 構造ビューア
N-(3-chlorophenyl)-2-(3-hydroxyphenyl)acetamide

ChemComp-H54: 構造ビューア
2-(3-methylphenyl)-N-(pyridin-3-yl)acetamide

ChemComp-H4G: 構造ビューア
2-(2,4-difluorophenyl)-N-(pyridin-3-yl)acetamide

ChemComp-H47: 構造ビューア
2-(3-methoxyphenyl)-N-(1,2-oxazol-3-yl)acetamide

ChemComp-H3V: 構造ビューア
N-(1,2-oxazol-3-yl)-2-phenylacetamide

ChemComp-H0M: 構造ビューア
2-(3-hydroxyphenyl)-N-(pyridin-2-yl)acetamide

ChemComp-H0G: 構造ビューア
2-(3-methylphenyl)-N-(1,2-oxazol-3-yl)acetamide

ChemComp-H0A: 構造ビューア
1-[(2S)-2-(4-methoxyphenyl)-2,3,6,7-tetrahydro-1H-azepin-1-yl]ethan-1-one

ChemComp-GZY: 構造ビューア
1-[(2S)-2-(3-methoxyphenyl)pyrrolidin-1-yl]ethan-1-one

ChemComp-H31: 構造ビューア
1-(4'-methyl[1,1'-biphenyl]-2-yl)pyrrolidin-2-one / 1-(4′-メチル-2-ビフェニリル)ピロリジン-2-オン

ChemComp-H2M: 構造ビューア
1-[3'-(trifluoromethyl)[1,1'-biphenyl]-2-yl]-1,3-dihydro-2H-pyrrol-2-one

ChemComp-H1P: 構造ビューア
1-(4'-fluoro[1,1'-biphenyl]-2-yl)-1,3-dihydro-2H-pyrrol-2-one

ChemComp-H1G: 構造ビューア
2-(4-methoxyphenyl)-N-{5-[2-oxo-2-(3-oxopiperazin-1-yl)ethoxy]pyridin-3-yl}acetamide

ChemComp-H17: 構造ビューア
2-{3-[(2R)-1-acryloylpyrrolidin-2-yl]phenyl}-N-(3-chlorophenyl)acetamide

ChemComp-H5D: 構造ビューア
2-{3-[(2S)-1-acetylpyrrolidin-2-yl]phenyl}-N-(3-chlorophenyl)acetamide

ChemComp-IOD: 構造ビューア
IODIDE ION / ヨ-ジド

ChemComp-EDO: 構造ビューア
1,2-ETHANEDIOL / エチレングリコ-ル

ChemComp-GOJ: 構造ビューア
ethyl 1~{H}-pyrazole-4-carboxylate / 1H-ピラゾ-ル-4-カルボン酸エチル

ChemComp-GOV: 構造ビューア
(2S)-1-{[(2H-1,3-benzodioxol-5-yl)methyl]amino}propan-2-ol

ChemComp-GOY: 構造ビューア
di(piperidin-1-yl)methanone / ジピペリジノケトン

ChemComp-GQ7: 構造ビューア
[5-(4-aminophenyl)furan-2-yl]methanol

ChemComp-GQA: 構造ビューア
1-methyl-3-oxidanyl-pyridine-2-thione / 1-メチル-3-ヒドロキシピリジン-2(1H)-チオン

ChemComp-GQJ: 構造ビューア
methyl (2~{S},4~{R})-1-(furan-2-ylcarbonyl)-4-oxidanyl-pyrrolidine-2-carboxylate

ChemComp-GQM: 構造ビューア
5-methoxy-2-(1~{H}-pyrazol-3-yl)phenol

ChemComp-GQP: 構造ビューア
1-[(4-fluorophenyl)methyl]benzimidazole / 1-(4-フルオロベンジル)-1H-ベンゾイミダゾ-ル

ChemComp-GQS: 構造ビューア
N-(3-fluorophenyl)-5-methyl-1,3,4-thiadiazol-2-amine

ChemComp-GQV: 構造ビューア
1-methyl-3-oxidanyl-pyridin-2-one / 3-ヒドロキシ-1-メチルピリジン-2(1H)-オン

ChemComp-CL: 構造ビューア
Unknown entry / クロリド

ChemComp-9KS: 構造ビューア
N-(2-hydroxyphenyl)acetamide / N-(2-ヒドロキシフェニル)アセトアミド

ChemComp-GRV: 構造ビューア
2-methyl-~{N}-(2-methylpropyl)imidazo[1,2-a]pyridine-3-carboxamide

ChemComp-GRY: 構造ビューア
~{N}1-(4,6-dimethylpyrimidin-2-yl)benzene-1,4-diamine

ChemComp-GT4: 構造ビューア
~{N}-(4-hydroxyphenyl)-2-methoxy-ethanamide

ChemComp-GT7: 構造ビューア
2-cyano-~{N}-cyclohexyl-ethanamide / N-シクロヘキシル-2-シアノアセトアミド

ChemComp-GTJ: 構造ビューア
~{N}-(1-propylbenzimidazol-2-yl)propanamide

ChemComp-GUG: 構造ビューア
~{N}-propan-2-ylquinoline-2-carboxamide

ChemComp-GUV: 構造ビューア
1-methyl-3-[3-(2-methylpyrimidin-4-yl)phenyl]urea

ChemComp-GUY: 構造ビューア
~{N}-(1-propyl-1,2,3,4-tetrazol-5-yl)furan-2-carboxamide

ChemComp-GV4: 構造ビューア
2-cyano-~{N}-(1,3,5-trimethylpyrazol-4-yl)ethanamide

ChemComp-GVV: 構造ビューア
~{N}-(4-methyl-2-oxidanyl-phenyl)propanamide

ChemComp-GWA: 構造ビューア
~{N}-(3-acetamidophenyl)-2-methoxy-ethanamide

ChemComp-FNR: 構造ビューア
1-DEOXY-1-(7,8-DIMETHYL-2,4-DIOXO-3,4-DIHYDRO-2H-BENZO[G]PTERIDIN-1-ID-10(5H)-YL)-5-O-PHOSPHONATO-D-RIBITOL / 還元型フラビンモノヌクレオチド

ChemComp-GX7: 構造ビューア
5-(cyclohexylamino)pyrimidine-2,4(1H,3H)-dione / 5-(シクロヘキシルアミノ)ウラシル

ChemComp-FMN: 構造ビューア
FLAVIN MONONUCLEOTIDE / FMN

ChemComp-GX4: 構造ビューア
cyclopropyl-[4-(4-fluorophenyl)piperazin-1-yl]methanone

ChemComp-GWY: 構造ビューア
5-chloranyl-~{N}-methyl-~{N}-[[(3~{S})-oxolan-3-yl]methyl]pyrimidin-4-amine

ChemComp-GWV: 構造ビューア
~{N},~{N}-dimethyl-4-[(propan-2-ylamino)methyl]aniline

ChemComp-GWS: 構造ビューア
2-cyclohexyl-~{N}-pyridin-3-yl-ethanamide

ChemComp-GWP: 構造ビューア
2-cyclopropyl-1~{H}-imidazole-4-carboxamide

ChemComp-GWG: 構造ビューア
1-methylindazole-3-carboxamide

ChemComp-MG: 構造ビューア
Unknown entry / マグネシウムジカチオン

ChemComp-K04: 構造ビューア
(2S,3S)-3-methyl-N-(1,2,3-thiadiazol-5-yl)tetrahydrofuran-2-carboxamide (non-preferred name)

ChemComp-JMM: 構造ビューア
[4-(cyclopropanecarbonyl)piperazin-1-yl](furan-2-yl)methanone

ChemComp-ELQ: 構造ビューア
[3,4-bis(fluoranyl)phenyl]-(4-methylpiperazin-1-yl)methanone

ChemComp-K0D: 構造ビューア
[(2R,5S)-2,5-dimethylmorpholin-4-yl](1,2,5-thiadiazol-3-yl)methanone

ChemComp-K0A: 構造ビューア
(2,5-dimethyl-1,3-thiazol-4-yl)(pyrrolidin-1-yl)methanone

ChemComp-K07: 構造ビューア
5-chloro-N-methyl-N-{[(3R)-oxolan-3-yl]methyl}pyrimidin-4-amine

ChemComp-K0J: 構造ビューア
N-ethyl-1H-1,2,3-triazole-4-carboxamide

ChemComp-K0M: 構造ビューア
3-methyl-N-(1-methyl-1H-pyrazol-3-yl)-1,2-oxazole-5-carboxamide

ChemComp-K0P: 構造ビューア
N-[(1-ethyl-1H-pyrazol-4-yl)methyl]pyridine-3-carboxamide

ChemComp-K0S: 構造ビューア
N-(5-propyl-1,3,4-thiadiazol-2-yl)pyridine-2-carboxamide

ChemComp-K0V: 構造ビューア
methyl 1-(tert-butylcarbamoyl)piperidine-4-carboxylate

ChemComp-K0Y: 構造ビューア
methyl N-(5-methyl-1,2-oxazole-3-carbonyl)glycinate

ChemComp-K1A: 構造ビューア
3-[(3,5-dimethyl-1,2-oxazol-4-yl)methyl]-5-methyl-1,3,4-thiadiazol-2(3H)-one

ChemComp-6SU: 構造ビューア
methyl 3-(methylsulfonylamino)benzoate / 3-(メチルスルホニルアミノ)安息香酸メチル

ChemComp-K1D: 構造ビューア
6-(azetidin-1-yl)-9H-purine

ChemComp-JJM: 構造ビューア
1-methyl-N-(3-methylphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine

ChemComp-K1G: 構造ビューア
N,1-dimethyl-N-(propan-2-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine

ChemComp-K1J: 構造ビューア
(2S,3R)-2,3-dimethyl-4-(3-methyl-1,2,4-thiadiazol-5-yl)morpholine

ChemComp-K41: 構造ビューア
2-methyl-N-(2-methyl-2H-tetrazol-5-yl)propanamide

ChemComp-K1P: 構造ビューア
1-(3-methyl-1,2,4-thiadiazol-5-yl)-1,4-diazepane

ChemComp-K1S: 構造ビューア
N,N-diethyl-5-methyl[1,2,4]triazolo[1,5-a]pyrimidin-7-amine / トラピジル / アンタゴニスト*YM

ChemComp-K1V: 構造ビューア
(3R)-1-acetylpiperidine-3-carboxamide

ChemComp-K1Y: 構造ビューア
methyl (2-methyl-4-phenyl-1,3-thiazol-5-yl)carbamate

ChemComp-K24: 構造ビューア
N,2-dimethyl-1,3-thiazole-5-carboxamide

ChemComp-K2G: 構造ビューア
5-chloro-2-(propan-2-yl)pyrimidine-4-carboxamide

ChemComp-K2J: 構造ビューア
4-methoxy-N-methylpyrimidin-2-amine

ChemComp-K2M: 構造ビューア
4-(furan-2-carbonyl)piperazine-1-carboxamide

ChemComp-K2P: 構造ビューア
2-(trifluoromethoxy)benzoic acid / 2-(トリフルオロメトキシ)安息香酸

ChemComp-K2S: 構造ビューア
N,N,3,5-tetramethyl-1H-pyrazole-4-sulfonamide

ChemComp-K2V: 構造ビューア
(1R)-1-[4-(pyrimidin-5-yl)phenyl]ethan-1-amine

ChemComp-K31: 構造ビューア
2-(3,5-dimethyl-1H-pyrazol-4-yl)aniline

ChemComp-K34: 構造ビューア
5-(1,3-thiazol-2-yl)-1H-1,2,4-triazole

ChemComp-JH4: 構造ビューア
N-methylpyrimidin-2-amine / 2-(メチルアミノ)ピリミジン

ChemComp-K3A: 構造ビューア
N-(5-methyl-1H-pyrazol-3-yl)acetamide / 3-(アセチルアミノ)-5-メチル-1H-ピラゾ-ル

ChemComp-K3D: 構造ビューア
4-acetyl-N-ethylpiperazine-1-carboxamide

ChemComp-K3J: 構造ビューア
N-ethyl-6-methylpyridazin-3-amine

ChemComp-K3M: 構造ビューア
2-fluoro-4-methylbenzamide

ChemComp-K3P: 構造ビューア
5-chloro-4-[(1-methyl-1H-pyrazol-4-yl)oxy]pyrimidine

ChemComp-K3S: 構造ビューア
N-[(1-methyl-1H-1,2,3-triazol-4-yl)methyl]ethanamine

ChemComp-K3V: 構造ビューア
7,8-dimethoxyphthalazin-1(2H)-one / 7,8-ジメトキシ-1,2-ジヒドロフタラジン-1-オン

ChemComp-K3Y: 構造ビューア
1-methyl-3-[(3R)-piperidin-3-yl]-1H-pyrazole-4-carboxamide